These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30421383)

  • 21. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
    Cho YA; Gwak HS
    Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
    Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
    Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women.
    Zeng J; Xie TF; Huang T; Li F; Wang ZP; Feng LL
    AAPS PharmSciTech; 2022 Feb; 23(3):79. PubMed ID: 35212788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug.
    Moser K; Kriwet K; Froehlich C; Kalia YN; Guy RH
    Pharm Res; 2001 Jul; 18(7):1006-11. PubMed ID: 11496937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical delivery of hexamidine.
    Parisi N; Paz-Alvarez M; Matts PJ; Lever R; Hadgraft J; Lane ME
    Int J Pharm; 2016 Jun; 506(1-2):332-9. PubMed ID: 27130367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Transcutol CG on the skin accumulation and transdermal permeation of ultraviolet absorbers.
    Godwin DA; Kim NH; Felton LA
    Eur J Pharm Biopharm; 2002 Jan; 53(1):23-7. PubMed ID: 11777749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical delivery of climbazole to mammalian skin.
    Paz-Alvarez M; Pudney PDA; Hadgraft J; Lane ME
    Int J Pharm; 2018 Oct; 549(1-2):317-324. PubMed ID: 30055301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D; Ali J; Baboota S
    Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
    Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
    Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel.
    Zhang Y; Zhang K; Guo T; Li Y; Zhu C; Feng N
    Int J Pharm; 2015 Feb; 479(1):219-26. PubMed ID: 25543112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoliposomes@Transcutol for
    Sinico C; Maria Fadda A; Valenti D; Pireddu R; Corrias F; Schlich M; Pitzanti G; Lai F
    J Nanosci Nanotechnol; 2021 May; 21(5):2901-2906. PubMed ID: 33653456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycols: The ubiquitous solvent for dermal formulations.
    Yu HL; Goh CF
    Eur J Pharm Biopharm; 2024 Mar; 196():114182. PubMed ID: 38224756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies.
    Panchagnula R; Ritschel WA
    J Pharm Pharmacol; 1991 Sep; 43(9):609-14. PubMed ID: 1685517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin.
    Caon T; Campos CE; Simões CM; Silva MA
    Int J Pharm; 2015 Oct; 494(1):463-70. PubMed ID: 26319631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro-in vivo correlation in skin permeation.
    Mohammed D; Matts PJ; Hadgraft J; Lane ME
    Pharm Res; 2014 Feb; 31(2):394-400. PubMed ID: 23943545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.
    Gorukanti SR; Li L; Kim KH
    Int J Pharm; 1999 Dec; 192(2):159-72. PubMed ID: 10567747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid lipid nanoparticles for targeted delivery of triclosan into skin for infection prevention.
    Kakadia PG; Conway BR
    J Microencapsul; 2018; 35(7-8):695-704. PubMed ID: 30699002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.